NZ609186A - Novel anti-cancer agents - Google Patents

Novel anti-cancer agents

Info

Publication number
NZ609186A
NZ609186A NZ609186A NZ60918611A NZ609186A NZ 609186 A NZ609186 A NZ 609186A NZ 609186 A NZ609186 A NZ 609186A NZ 60918611 A NZ60918611 A NZ 60918611A NZ 609186 A NZ609186 A NZ 609186A
Authority
NZ
New Zealand
Prior art keywords
cancer agents
novel anti
imidazolidine
triazin
amino
Prior art date
Application number
NZ609186A
Other languages
English (en)
Inventor
Antony Wilks Burgess
Francesca Walker
Keith Geoffrey Watson
Helen Witchard
Guillaume Lessene
Original Assignee
Inst Medical W & E Hall
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Medical W & E Hall filed Critical Inst Medical W & E Hall
Publication of NZ609186A publication Critical patent/NZ609186A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ609186A 2010-10-27 2011-10-27 Novel anti-cancer agents NZ609186A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40726510P 2010-10-27 2010-10-27
PCT/AU2011/001376 WO2012054978A1 (en) 2010-10-27 2011-10-27 Novel anti-cancer agents

Publications (1)

Publication Number Publication Date
NZ609186A true NZ609186A (en) 2015-08-28

Family

ID=45992970

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ609186A NZ609186A (en) 2010-10-27 2011-10-27 Novel anti-cancer agents

Country Status (12)

Country Link
US (3) US8835629B2 (enExample)
EP (1) EP2632916B1 (enExample)
JP (2) JP6184866B2 (enExample)
KR (1) KR101896924B1 (enExample)
CN (1) CN103476769B (enExample)
AU (1) AU2011320024B2 (enExample)
CA (1) CA2814120C (enExample)
ES (1) ES2621932T3 (enExample)
HU (1) HUE032522T2 (enExample)
NZ (1) NZ609186A (enExample)
PL (1) PL2632916T3 (enExample)
WO (1) WO2012054978A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2621932T3 (es) * 2010-10-27 2017-07-05 The Walter And Eliza Hall Institute Of Medical Research Agentes antineoplásicos novedosos
KR101853785B1 (ko) 2013-11-20 2018-05-02 주식회사 만도 3상모터 제어장치 및 그의 고토크 유지 방법
WO2016070241A1 (en) * 2014-11-03 2016-05-12 Ctxt Pty Ltd Triazine compounds, compositions and synthesis
WO2018226923A1 (en) * 2017-06-08 2018-12-13 University Of South Alabama Antimicrobial compounds
CN111902403B (zh) 2018-01-17 2024-05-17 奥里吉恩发现科技有限公司 作为抗癌剂的取代的亚炔基化合物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1035771A (enExample)
US2742466A (en) 1956-04-17 Chx n nhx c c
US3145203A (en) 1961-11-30 1964-08-18 Geigy Chem Corp Hydrazones of 5-nitro-2-furaldehyde
JPS5277163A (en) 1975-12-24 1977-06-29 Asahi Chem Ind Co Ltd Stabilized polyurethane composition
FR2524467A1 (fr) 1982-03-30 1983-10-07 Adir Polymethylene-imines disubstituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
JPS62192474A (ja) 1986-02-19 1987-08-24 Canon Inc 記録液
US4932998A (en) 1986-09-30 1990-06-12 Idemitsu Kosan Company Limited Triazine derivatives, and herbicides comprising the same as the effective ingredient
US4844731A (en) 1986-12-27 1989-07-04 Idemitsu Company Co., Ltd. Triazine derivatives
US5187045A (en) 1988-09-07 1993-02-16 Minnesota Mining And Manufacturing Company Halomethyl-1,3,5-triazines containing a sensitizer moiety
CA2027562C (en) 1989-02-20 1994-05-10 Masahiro Nishii Triazine derivative and a herbicide comprising the same as an effective ingredient
US5536722A (en) 1991-11-12 1996-07-16 Pfizer Inc. Triazine derivatives for enhancing antitumor activity
DE69322076D1 (de) 1992-02-28 1998-12-17 Zenyaku Kogyo Kk S-triazin-derivate und diese als aktiven wirkstoff enthaltende heilmittel gegen östrogen abhängige krankheiten
US5574057A (en) 1993-02-03 1996-11-12 University Of Utah Research Foundation Naamidine A extracted from sea sponges and methods for its use as an anti-tumor agent
US6566384B1 (en) 1996-08-07 2003-05-20 Darwin Discovery Ltd. Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
FR2757056B1 (fr) 1996-12-17 2003-03-14 Oreal Compositions comprenant un derive de dibenzoylmethane, un derive de 1,3,5-triazine et un compose amide et utilisations
FR2757057A1 (fr) 1996-12-17 1998-06-19 Oreal Compositions comprenant un derive de dibenzoylmethane, un derive de 1,3,5-triazine et un derive silicie a fonction benzalmalonate et utilisations
EP0945447A1 (en) 1998-03-27 1999-09-29 Janssen Pharmaceutica N.V. Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections
US6262053B1 (en) 1999-06-23 2001-07-17 Parker Hughes Institute Melamine derivatives as potent anti-cancer agents
EP2404603A1 (en) * 2000-10-23 2012-01-11 Glaxosmithkline LLC Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds for the treatment of CSBP/p38 kinase mediated diseases
US7173032B2 (en) * 2001-09-21 2007-02-06 Reddy Us Therapeutics, Inc. Methods and compositions of novel triazine compounds
EP1441683A4 (en) 2001-10-12 2005-10-26 Univ New York TRISUBSTITUTED TRIAZIN COMPOUNDS AND METHOD FOR THE PREPARATION AND USE OF THE COMPOUNDS WITH ANTITUBULIN EFFECT
CN1697831A (zh) * 2002-09-23 2005-11-16 雷迪美国治疗公司 新三嗪化合物的制备方法和组合物
ES2621932T3 (es) * 2010-10-27 2017-07-05 The Walter And Eliza Hall Institute Of Medical Research Agentes antineoplásicos novedosos

Also Published As

Publication number Publication date
CN103476769A (zh) 2013-12-25
PL2632916T3 (pl) 2017-07-31
US20150045365A1 (en) 2015-02-12
AU2011320024A1 (en) 2013-05-02
EP2632916A4 (en) 2014-04-23
AU2011320024B2 (en) 2014-10-30
JP2013540778A (ja) 2013-11-07
ES2621932T3 (es) 2017-07-05
CA2814120A1 (en) 2012-05-03
US20130261119A1 (en) 2013-10-03
WO2012054978A1 (en) 2012-05-03
KR101896924B1 (ko) 2018-09-10
EP2632916B1 (en) 2017-01-11
CA2814120C (en) 2018-08-07
HUE032522T2 (en) 2017-09-28
US20160145243A1 (en) 2016-05-26
EP2632916A1 (en) 2013-09-04
US9221799B2 (en) 2015-12-29
JP6184866B2 (ja) 2017-08-23
JP2017137323A (ja) 2017-08-10
CN103476769B (zh) 2016-06-01
KR20130141554A (ko) 2013-12-26
US8835629B2 (en) 2014-09-16

Similar Documents

Publication Publication Date Title
NZ593004A (en) Azaazulene compounds
NZ591449A (en) Picolinamide derivatives as kinase inhibitors
MX2010008040A (es) Derivados de pirimidina 5-fluoro como fungicidas.
NZ596488A (en) 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of cyp 17
MX2010010317A (es) Compuestos heterociclicos novedosos y usos de los mismos.
MX2010009416A (es) Compuestos heterociclicos como inhibidores de cxcr2.
TNSN08227A1 (en) [4-(benzo [b] thi0phen-2-yl) pyrimidin-2yl] -amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases.
PH12012501905A1 (en) Quinoline derivatives and their use as fungicides
NZ620020A (en) Heterocyclic compounds and uses thereof
MX2009012708A (es) Derivados de piridazinona.
MY155719A (en) 2-benzylpyridazinone derivatives as met kinase inhibitors
PH12012500674A1 (en) Heterocyclic compounds useful as pdk1 inhibitors
TW200714604A (en) Substituted heterocycles and the uses thereof
NZ619205A (en) Antiviral compounds
EA201071234A1 (ru) Производные изохинолинона в качестве nk3 антагонистов
CL2012001221A1 (es) Compuestos derivados de 4 -(1h-pirrol-1-il) pirimidin -2-ilamino y 4 -(1h-pirazol-1-il)- pirimidin-2-ilamino, inhibidores de quinasa; un compuesto isomerico; composicion farmaceutica; utiles en el tratamiento del asma, enfermedad pulmonar obstructiva cronica, colitis ulcerante, enfermedad de crohn, bronquitis, dermatitis, entre otras.
WO2009046842A3 (de) Thialzolderivate zur behandlung von krebs
WO2010000364A8 (de) Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate
EA201100835A1 (ru) Защитная композиция из 6-(тризамещенных фенил)-4-амино-2-пиридинкарбоксилатных гербицидов и клоквинтоцета для злаковых культур
NZ611528A (en) Neprilysin inhibitors
MX2012004264A (es) Derivados de sulfoxidos para el tratamiento de tumores.
MX342947B (es) Tratamiento de diabetes tipo 2.
UA101963C2 (en) 4-amino-pyrimidine derivatives
MX2011007165A (es) Derivados de piridazinona.
WO2009156041A3 (de) Thiazolyl-piperidinderivate

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 27 OCT 2018 BY FB RICE

Effective date: 20151203

LAPS Patent lapsed